Clarifier — Needle‑free prevention vs emergency rescue

• Prevention (SLIT): Daily, under‑the‑tongue tablets (grass, ragweed, dust mite) or physician‑directed drops to desensitize your immune system over time. Goal: long‑term control and relief.

• Rescue (epinephrine, incl. nasal): For severe reactions (anaphylaxis) only. Use immediately at first signs of a systemic reaction, then call 911. It does not control day‑to‑day allergy symptoms.

Learn the basics → What is anaphylaxis?> Needle‑free allergy treatments, doctor‑led and at home

Prefer a needle‑free path for allergic rhinitis? Wyndly’s board‑certified physicians provide FDA‑labeled SLIT tablets when appropriate and personalized oral drops for multi‑allergen disease—from $99/month with a 90‑day Allergy‑Free Guarantee. Learn more: Wyndly Immunotherapy.

Needle‑free allergy treatments for busy professionals

Quick clarifier: “needle‑free” SLIT vs rescue devices

When we say needle‑free, we mean sublingual immunotherapy (SLIT) taken under the tongue as daily tablets (FDA‑approved for grass, ragweed, dust mite) or physician‑directed drops for multi‑allergen disease. SLIT is preventive and disease‑modifying; it is not the same as emergency rescue medicines.

• What SLIT is: A daily, at‑home therapy that retrains your immune system to tolerate environmental allergens (pollen, dust mites, pet dander). Expect improvement in weeks to months and long‑term benefit over ~3 years. Learn more → Wyndly Immunotherapy and tablet timing below.

• What rescue is: Epinephrine (auto‑injector or nasal) is for anaphylaxis emergencies only. It does not control day‑to‑day allergic rhinitis. Use at first signs of a severe reaction and call 911. See What is anaphylaxis? and our Patient FAQs.

• First‑dose safety: FDA‑labeled SLIT tablets require the very first dose to be supervised with ≥30 minutes of observation, plus epinephrine education per product labeling. Custom liquid SLIT (drops) follows physician‑directed protocols at home. Overview → UpToDate on SLIT

• What we don’t treat: We focus on environmental (not food) allergies. If you have a history of anaphylaxis, continue to carry epinephrine as prescribed while on SLIT.

FAQ — common “needle‑free” questions

• Does “needle‑free” mean no shots ever? Yes—SLIT uses tablets or drops under the tongue. Tablet first doses are supervised; ongoing dosing is at home.

• Is epinephrine nasal spray part of my daily plan? No. It’s emergency‑only rescue, not a controller. Keep it if prescribed, but it is separate from SLIT.

• Who isn’t a fit for SLIT? People with uncontrolled/severe asthma, eosinophilic esophagitis (EoE), current pregnancy, or those on beta blockers may not be candidates (see our Patient FAQs).

We deliver needle‑free allergy treatments that fit into your workday—start from home in minutes.Wyndly offers needle‑free allergy treatment for busy professionals, travelers, and families who want doctor‑led care without clinic visits.

• Book in 2 minutes and complete testing and treatment 100% at home; your first visit is with a board‑certified physician

• Doctor‑led SLIT tablets (grass, ragweed, dust mite) or custom drops for multi‑allergen disease; see our pollen program → Pollen Immunotherapy

• Clear pricing and protection: $99/month, HSA/FSA eligible, with a 90‑day Allergy‑Free Guarantee → Pricing & Guarantee

• Results begin in 4–24 weeks for most; long‑term immune remodeling over ~3 years with 24/7 doctor access

TL;DR — start windows and quick links (1‑screen)

• Who it’s for: busy professionals, frequent travelers, needle‑averse patients, and families (ages 5+)

• Start‑by windows (tablets)

• Grass tablets: start ≥12 weeks before season for Grastek; ≥4 months for Oralair; continue through season. Details → Grass tablet start timing

• Ragweed tablet (Ragwitek): start ≥12 weeks before ragweed season; continue through season

• Dust‑mite tablet (Odactra): start anytime; taken year‑round

• Start‑by windows (at‑home drops)

• Start anytime; for pollen‑predominant symptoms, ideal 8–12 weeks before peak season; can also begin in‑season for multi‑allergen care

• Safety & first dose

• Tablets: first dose supervised with ≥30‑minute observation; carry prescribed epinephrine per label

• Drops: at‑home dosing under physician‑directed protocol

• Check today’s pollen index before you start or travel → Pollen Index (by ZIP)

• Book in 2 minutes and complete testing and treatment 100% at home; your first visit is with a board‑certified physician

• Doctor‑led SLIT tablets (grass, ragweed, dust mite) or custom drops for multi‑allergen disease; see our pollen program → Pollen Immunotherapy

• Clear pricing and protection: $99/month, HSA/FSA eligible, with a 90‑day Allergy‑Free Guarantee → Pricing & Guarantee

• Results begin in 4–24 weeks for most; long‑term immune remodeling over ~3 years with 24/7 doctor access

Needle‑free options at a glance

Pet dander note: There are no FDA‑approved cat or dog tablets. For pet allergies, physicians use personalized SLIT drops to desensitize to pet dander at home under medical guidance (Pet allergy immunotherapy).

TL;DR for busy professionals: control vs SLIT vs rescue

• Built for busy professionals, travelers, and needle‑averse patients

• 100% at‑home testing and treatment; ages 5+; 24/7 doctor access

• FDA‑labeled SLIT tablets when appropriate; physician‑directed drops for multi‑allergen disease

• 90‑day Allergy‑Free Guarantee; HSA/FSA eligible

Ready to get started?

• Schedule a free online visit (2 minutes to book): Book a consult

• Prefer to pick a time now? Use our scheduler: Schedule with an expert

Needle‑free for busy professionals — start in minutes

• Book a quick virtual visit to personalize your plan: Free online consult

• Prefer to test first? Order an at‑home, CLIA‑certified kit: At‑home allergy test

• Doctor‑led SLIT tablets or drops, $99/month, 24/7 access, 90‑day Allergy‑Free Guarantee

Compare INCS vs SLIT vs shots (evidence snapshot)

References accessed November 2025.

Needle‑free allergy treatments for busy professionals and families

Bottom line up front: SLIT is preventive, long‑term desensitization; epinephrine is emergency rescue only. For safety steps and what to expect, see our Safety FAQ: Wyndly Patient FAQs.

Updated quick comparison (controllers vs rescue)

• Onset at a glance

• INCS: hours to days; maximal effect over days–weeks

• Azelastine/fluticasone combo: often within days

• SLIT tablets: weeks, with best outcomes when started pre‑season for pollens

• SLIT drops (off‑label in the U.S.): weeks to months

• Safety first

• First SLIT tablet dose under medical supervision with ≥30 minutes of observation; prescribe and teach use of an epinephrine auto‑injector per product labeling (grass, ragweed, dust‑mite tablets)

• SLIT has a favorable safety profile vs shots in independent reviews; severe reactions are very rare. See Cochrane review and society guidance referenced below

• Good fits

• Patients who want needle‑free care, have limited clinic access, travel frequently, or are managing multi‑allergen disease under physician oversight

Needle‑free treatments for dust mite and pet dander

• Targets common indoor triggers year‑round: dust mites and pet dander (cats, dogs, horses)

• Options: FDA‑labeled SLIT tablet for dust mites (first dose supervised) or physician‑directed SLIT drops for multi‑allergen disease

• At‑home, painless dosing; most notice improvement in 4–24 weeks; 3 years for long‑term remodeling

• Learn more: Dust mite allergy and SLIT drops (how it works, home controls, timelines) → Dust mite allergies

• Considering pet dander therapy? See indications, timelines, and pricing → Pet allergy immunotherapy

Pet dander (for people): needle‑free care that fits your life

There are no FDA‑approved SLIT tablets for cats or dogs. For pet allergies, doctors use physician‑directed sublingual drops (off‑label in the U.S.) to desensitize you at home under medical oversight.

• What we treat: cat, dog, and horse dander (often alongside dust mites and pollens)

• Who it helps: adults and kids 5+, frequent travelers, needle‑averse patients, multi‑allergen profiles

• Safety: favorable profile vs shots in independent reviews; severe reactions are very rare (Cochrane)

Get started

• Cat allergies → Cat allergy immunotherapy

• Dog allergies → Dog allergy immunotherapy

• Horse or other pet dander → Pet allergy immunotherapy or learn more → Horse allergies

No‑shots comparison (at a glance)

Treat allergies from home with doctor oversight

• Start with an at‑home, CLIA‑certified test (40+ indoor/outdoor allergens), then meet a board‑certified physician

• Personalized SLIT plan shipped to your door; $99/month, HSA/FSA eligible; 90‑day Allergy‑Free Guarantee; ages 5+

• Safety basics: supervised first tablet dose, epinephrine education as labeled; ongoing check‑ins and 24/7 support

• What to expect, side effects, and refills → Wyndly Patient FAQs

How clinicians sequence needle‑free options for allergic rhinitis

This page distills the conservative, guideline‑concordant order most clinicians use before injections: 1) intranasal corticosteroid (INCS) monotherapy, 2) azelastine/fluticasone combination spray for inadequate control, 3) FDA‑approved sublingual immunotherapy (SLIT) tablets with supervised first dose, epinephrine, and pre‑season start, and 4) SLIT allergy drops (off‑label in the U.S.) for multi‑allergen disease under physician oversight. Where relevant, we link to neutral medical sources and Wyndly’s evidence pages for additional context.

1) Intranasal corticosteroids (INCS) are first‑line

• What they are: Once‑daily steroid sprays (e.g., fluticasone, budesonide, mometasone) that reduce nasal mucosal inflammation.

• Why first: Major guidelines designate INCS as preferred monotherapy for persistent allergic rhinitis; they reduce congestion, rhinorrhea, sneezing, and itch better than oral antihistamines in most trials. See the AAAAI/ACAAI Joint Task Force rhinitis update and an AAFP evidence review. Rhinitis 2020 practice parameter, AAFP 2023 Rapid Evidence Review, AAFP guideline summary of JTF parameter.

• Practical use: Daily use during pollen seasons (or year‑round for perennial triggers); onset begins within hours with maximal effect after days to weeks. Common effects: local dryness/epistaxis; rare ocular effects with long‑term use are noted in guidelines.

2) If symptoms persist: add a combination intranasal antihistamine + steroid

• What it is: A single spray combining azelastine (antihistamine) with fluticasone (steroid).

• Why add: Randomized trials and meta‑analyses show superior symptom control versus either component alone; the JTF update supports additive benefit when monotherapy is insufficient. Systematic review/meta‑analysis, RCTs, AAFP discussion, Rhinitis 2020.

• Practical use: Twice‑daily dosing is common in trials; counsel on bitter taste and possible mild sedation from azelastine.

3) When to use SLIT tablets (FDA‑approved) and how to do it safely

SLIT tablets are needle‑free immunotherapy that desensitize the immune system to a single allergen. In the U.S., tablets exist for grass pollens (Oralair, Grastek), ragweed (Ragwitek), and house dust mite (Odactra). Efficacy and safety are supported by large trials and independent reviews, and guidelines consider SLIT a disease‑modifying option for appropriately selected patients.

• Indications and timing (per FDA labeling and AAAAI patient summaries):

• Grass (Grastek; Oralair): start before the season (Grastek ≥12 weeks; Oralair typically ≥4 months) and continue through it.

• Ragweed (Ragwitek): start ≥12 weeks before ragweed season and continue through it.

• Dust mite (Odactra): start any time and take year‑round.

• First dose supervision and epinephrine:

• FDA labeling requires the first dose to be administered under healthcare supervision with ≥30 minutes of observation; prescribers should provide/teach use of an epinephrine auto‑injector for home dosing.

• Contraindications/cautions (tablets): severe or uncontrolled asthma, history of severe systemic or severe local SLIT reactions, eosinophilic esophagitis; caution with conditions or drugs that complicate epinephrine use. See each product label for full details.

• Evidence base: SLIT provides clinically meaningful reductions in symptoms and rescue meds; high‑quality reviews (e.g., Cochrane) support efficacy and favorable safety. Cochrane SLIT review.

4) SLIT allergy drops: off‑label in the U.S., often chosen for multi‑allergen disease

• Regulatory status and scope: Custom‑mixed liquid SLIT (“allergy drops”) are not FDA‑approved in the U.S.; their use is off‑label, typically when patients are sensitized to multiple clinically relevant allergens or when a tablet does not exist for the target allergen. ACAAI/AAAAI patient summary, AAO‑HNS bulletin, Review of SLIT tablets vs drops.

• Safety and outcomes: Large systematic reviews (including Cochrane) show SLIT reduces symptoms and has a very low rate of severe reactions; drops share this profile in observational data, though the tablet evidence base is stronger. Cochrane SLIT review.

• Practical cautions: Because drops are off‑label, dosing standards, coverage, and pharmacies vary; choose physician‑directed programs that use medical‑grade extracts, track outcomes, and triage contraindications (uncontrolled asthma, EoE, etc.).

Quick comparison (needle‑free options)

Emergency vs long‑term: epinephrine is rescue; SLIT remodels disease

• What epinephrine is for: Epinephrine (auto‑injectors and nasal formulations such as neffy) is the first‑line emergency treatment for anaphylaxis. Use immediately at the first signs of a severe, systemic reaction and call 911. It is not for daily control of allergic rhinitis or asthma, and it does not prevent seasonal symptoms.

• What SLIT and daily controllers are for: Sublingual immunotherapy (SLIT) and guideline‑recommended controllers (e.g., intranasal steroids, azelastine/fluticasone) reduce symptoms and, in the case of SLIT, desensitize your immune system over months to years. SLIT is disease‑modifying; epinephrine is a rescue medicine.

• If you carry epinephrine: Continue to carry and know how to use it even while on SLIT if you have a history of anaphylaxis or have been instructed to do so. Your emergency plan remains unchanged.

• Learn more: What a severe reaction looks like and why epinephrine is critical: What is anaphylaxis?. Safety data comparing shots vs SLIT: Anaphylaxis with immunotherapy. How SLIT works and the evidence base: Wyndly Immunotherapy.

Last reviewed: October 2025Reviewed by: Dr. Manan Shah, MD (ENT), Wyndly co‑founder and Chief Medical Officer

Tablets vs drops vs sprays: quick guide (needle‑free options)

Note on supervision for tablets

• For SLIT tablets (grass, ragweed, dust mite), U.S. product labeling requires the first dose to be administered under healthcare supervision with at least 30 minutes of observation, and prescribers should provide and train on use of an epinephrine auto‑injector. This does not apply to custom liquid SLIT (drops), which follow physician‑directed protocols.

Where Wyndly fits (doctor‑led, needle‑free care)

Doctor‑supervised at‑home allergy care

How it works (step‑by‑step) 1) CLIA‑certified testing at home

• Finger‑prick blood test for 40+ indoor/outdoor allergens; results reviewed by a board‑certified physician. Start here: At‑home allergy test

2) Virtual MD consult

• Meet a U.S. board‑certified doctor to confirm your history, interpret results, and choose the safest option (FDA‑labeled SLIT tablets when appropriate, or physician‑directed drops for multi‑allergen disease). Book now: Consult a doctor

3) Personalized therapy, shipped to you

• Pharmacy prepares your plan and ships to your door; unlimited 24/7 access to the care team by text, phone, or email. See expectations and safety FAQs: Patient FAQs

Follow‑up cadence and monitoring

• Routine check‑ins (including a 90‑day review) with on‑demand messaging between visits; dosing adjustments based on symptoms and adherence.

• Outcome tracking focuses on symptom control and reduced rescue‑medication use (repeat testing is not required per our FAQs).

Escalation/contraindication screening

• We do not initiate SLIT in patients with: uncontrolled/severe asthma, eosinophilic esophagitis (EoE), mast cell activation syndrome (MCAS), current pregnancy, or those taking beta blockers (see product labels and FAQs for full details).

• Escalate for in‑person evaluation if red‑flag symptoms occur (e.g., chest tightness/wheezing, systemic hives, throat swelling). Use epinephrine at first signs of anaphylaxis and call 911; continue to carry epinephrine if prescribed.

First‑dose workflow for FDA‑labeled SLIT tablets (grass, ragweed, dust‑mite)

• Per FDA labeling: administer the very first dose under healthcare supervision with ≥30 minutes of observation and prescribe/teach use of an epinephrine auto‑injector for home dosing thereafter. Review labeling specifics in our Safety FAQ and tablet sections above.

What stays at home vs supervised

• SLIT tablets: first dose supervised, ongoing daily dosing at home.

• SLIT drops (off‑label in U.S.): daily home dosing under physician‑directed protocols and safety screening.

Helpful links

• Testing: At‑home allergy test

• Doctor visit: Consult a doctor

• Safety/first‑dose details: Wyndly Patient FAQs

Schema (Organization)

{
 "@context": "https://schema.org",
 "@type": "Organization",
 "name": "Wyndly",
 "url": "https://www.wyndly.com/",
 "description": "Doctor-led telehealth practice providing at-home allergy testing and sublingual immunotherapy (drops and FDA-labeled tablets) with 24/7 physician access.",
 "contactPoint": [{
 "@type": "ContactPoint",
 "contactType": "customer support",
 "email": "care@wyndly.com",
 "telephone": "+1-720-730-9988",
 "areaServed": "US"
 }],
 "address": [{
 "@type": "PostalAddress",
 "streetAddress": "169 Madison Ave #2137",
 "addressLocality": "New York",
 "addressRegion": "NY",
 "postalCode": "10016",
 "addressCountry": "US"
 }, {
 "@type": "PostalAddress",
 "streetAddress": "255 Union Boulevard",
 "addressLocality": "Lakewood",
 "addressRegion": "CO",
 "postalCode": "80228",
 "addressCountry": "US"
 }]
}

• Wyndly’s physicians use FDA‑approved SLIT tablets when appropriate and physician‑directed oral dosing (drops) for multi‑allergen disease, following the same clinical principles outlined above. See Wyndly Immunotherapy.

• Safety practices mirror labeling: first tablet dose under supervision, training in epinephrine auto‑injector use, and ongoing monitoring. Wyndly’s medical team also details SLIT safety and anaphylaxis risk profiles here: Are allergy drops safe?, Anaphylaxis with immunotherapy.

• Scope and limits: Wyndly treats environmental (not food) allergies and screens for contraindications (e.g., eosinophilic esophagitis, uncontrolled asthma), consistent with tablet labels and society guidance.

Key sources for further reading

• Practice parameters and clinical overviews: Rhinitis 2020 JTF update; AAAAI practice‑parameter portal; AAFP evidence reviews.

• SLIT efficacy/safety (independent evidence): Cochrane Review—SLIT for allergic rhinitis; Cochrane—ocular outcomes.

• FDA tablets and patient summaries: refer to FDA labeling and AAAAI tablet overview for additional information.

Notes on timing for U.S. readers (as of October 20, 2025): If you plan pollen‑tablet SLIT for Spring 2026, count backward to start by January–February (≥12 weeks for Grastek; often ≥4 months for Oralair). Dust‑mite SLIT can begin any time of year.